13例晚期非小细胞肺癌患者生存期相关因素分析

目的探讨中西医结合疗法延长晚期非小细胞肺癌(NSCLC)生存期的优越性和优势环节.方法对经中西医结合治疗的生存期在2年以上的晚期NSCLC患者13例进行回顾性分析.结果在应用以含铂类方案为主的化疗同时,中医的益气养阴法及理气化痰法是该组患者最为常用的治法;在所应用的中药静脉制剂中,以康莱特注射液、生脉注射液等使用频率最高;中药汤剂中以茯苓、陈皮、白术、黄芪、沙参等药物最为常用.结论中西医结合疗法延长晚期NSCLC生存期的优势环节可能在于中医药对化疗的减毒、增效作用以及中西药物间的协同与叠加作用;益气养阴治法及理气化痰治法在晚期NSCLC的中医治疗中占有重要地位.

Analysis on Correlation Factor in Lifetime of 13 Cases of Late Non-Small Cell Lung Cancer

Objective To discuss the superiority and advantage of the therapy integrated Chinese and western medicines to prolong the lifetime of patient with late non-small cell lung cancer (NSCLC). Method To review and analyze 13 cases of NSCLC treated with the therapy integrated Chinese and western medicines and had lived for 2 years. Result At the same time of using chemotherapy the TCM therapies of replenishing qi and ying, and regulating qi to reducing phlegm were the most commonly used principles for the patients. Among the venous preparations Kanglaite Injection and Shengmai Injection were used at the most frequency. In decoction tuckahoe, dried old orange peel, rhizome larghead atractylodos,root of Mongolian milkvetch,root of straight ladybell were in common use. Conclusion The advantage of the therapy integrated Chinese and western medicines to prolong the lifetime of the patient with NSCLC probably is that Chinese medicines can reduce the toxin of chemotherapy and promoting effect of it. There are cooperative and pileup effect between Chinese and western medicines. The treatment principles of replenishing qi and ying and regulating qi to reducing phlegm are important in the treatment of NSCLC with Chinese medicines.